Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
Sayre, P.H., Finer-Moore, J.S., Fritz, T.A., Biermann, D., Gates, S.B., MacKellar, W.C., Patel, V.F., Stroud, R.M.(2001) J Mol Biol 313: 813-829
- PubMed: 11697906 
- DOI: 10.1006/jmbi.2001.5074
- Primary Citation of Related Structures:  
1JTQ, 1JTU, 1JU6, 1JUT, 1JUJ - PubMed Abstract: 
Crystal structures of four pyrrolo(2,3-d)pyrimidine-based antifolate compounds, developed as inhibitors of thymidylate synthase (TS) in a strategy to circumvent drug-resistance, have been determined in complexes with their in vivo target, human thymidyla ...